| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
58,848 |
46,826 |
$16.66M |
| 00003 |
Internal/system code - not a standard HCPCS code |
22,915 |
18,581 |
$12.78M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,802 |
3,165 |
$392K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
51,394 |
43,515 |
$108K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,681 |
1,142 |
$22K |
| 0012A |
|
622 |
618 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,384 |
6,533 |
$19K |
| 0011A |
|
602 |
602 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,937 |
9,181 |
$11K |
| 0013A |
|
219 |
219 |
$9K |
| 97803 |
|
776 |
595 |
$8K |
| 97802 |
|
589 |
568 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,002 |
947 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
5,785 |
5,640 |
$867.58 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,552 |
5,145 |
$792.94 |
| 90688 |
|
1,123 |
1,117 |
$364.87 |
| 90832 |
Psychotherapy, 30 minutes with patient |
110 |
100 |
$227.30 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,873 |
6,594 |
$196.37 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
32 |
32 |
$123.48 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,464 |
4,371 |
$95.36 |
| 99173 |
|
5,672 |
5,525 |
$83.43 |
| 90715 |
|
1,326 |
1,319 |
$50.00 |
| 94760 |
|
1,887 |
1,765 |
$46.74 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,680 |
3,146 |
$37.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,339 |
1,287 |
$30.00 |
| 90686 |
|
1,722 |
1,710 |
$24.99 |
| 82962 |
|
4,139 |
3,914 |
$19.45 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,577 |
1,550 |
$17.70 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,119 |
1,740 |
$15.00 |
| 80061 |
Lipid panel |
13 |
13 |
$11.54 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
868 |
868 |
$7.33 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,480 |
2,410 |
$7.32 |
| 85018 |
|
4,780 |
4,599 |
$4.30 |
| 99000 |
|
6,783 |
6,554 |
$3.63 |
| 81002 |
|
3,021 |
2,860 |
$1.61 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,877 |
1,661 |
$0.00 |
| 99443 |
|
1,580 |
1,218 |
$0.00 |
| 93000 |
|
251 |
251 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
801 |
751 |
$0.00 |
| 99441 |
|
8,980 |
8,019 |
$0.00 |
| 90480 |
|
72 |
72 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
77 |
77 |
$0.00 |
| 90651 |
|
451 |
450 |
$0.00 |
| 96127 |
|
6,089 |
5,830 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
195 |
177 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
355 |
343 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
55 |
55 |
$0.00 |
| 90619 |
|
144 |
144 |
$0.00 |
| 99406 |
|
682 |
640 |
$0.00 |
| 86580 |
|
96 |
94 |
$0.00 |
| 90696 |
|
58 |
58 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
94 |
88 |
$0.00 |
| 90723 |
|
78 |
65 |
$0.00 |
| 90677 |
|
28 |
28 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
84 |
67 |
$0.00 |
| 90680 |
|
19 |
14 |
$0.00 |
| 90656 |
|
120 |
120 |
$0.00 |
| 36416 |
|
37 |
36 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
123 |
108 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
774 |
773 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,419 |
1,411 |
$0.00 |
| 92552 |
|
3,047 |
2,997 |
$0.00 |
| 81025 |
|
2,149 |
2,104 |
$0.00 |
| 99442 |
|
3,987 |
3,650 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
75 |
66 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,489 |
1,414 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
71 |
71 |
$0.00 |
| 90670 |
|
401 |
327 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,240 |
1,235 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
377 |
375 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
260 |
196 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
57 |
55 |
$0.00 |
| 90678 |
|
13 |
13 |
$0.00 |
| 90662 |
|
78 |
78 |
$0.00 |
| 90734 |
|
160 |
159 |
$0.00 |
| 90633 |
|
148 |
142 |
$0.00 |
| 90710 |
|
49 |
49 |
$0.00 |
| 90714 |
|
24 |
24 |
$0.00 |
| 90648 |
|
58 |
48 |
$0.00 |
| 91322 |
|
16 |
16 |
$0.00 |
| 90672 |
|
12 |
12 |
$0.00 |
| 90750 |
|
24 |
24 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
13 |
13 |
$0.00 |
| 69209 |
|
13 |
13 |
$0.00 |